{"title": "Product Overview| BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed) for HCPs", "author": null, "url": "https://gskpro.com/en-us/products/boostrix/", "hostname": "gskpro.com", "description": "Learn more about BOOSTRIX.", "sitename": "gskpro.com", "date": "2022-10-10", "cleaned_text": "4 Indications BOOSTRIX is indicated for: - active booster immunization against tetanus, diphtheria, and pertussis in individuals aged 10 years and older; - immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age. BOOSTRIX is the first Tdap vaccine indicated for use in pregnancy by the FDA. [1,2](#r1) Adacel is indicated for [3](#r3): - active booster immunization against tetanus, diphtheria and pertussis. Adacel is approved for use in persons 10 through 64 years of age. - immunization during the third trimester of pregnancy to prevent pertussis in infants younger than 2 months of age. *Tetanus, diphtheria, and acellular pertussis. U.S. Food and Drug Administration References: [Prescribing Information for BOOSTRIX.] [GSK Press Release. US FDA approves Boostrix for immunization during pregnancy for the prevention of whooping cough in newborn infants. October 10, 2022. Accessed January 20, 2023. "}